PHARMACEUTICALLY ELEGANT
DEAD

Serial Number

97227033

Owner

AQUESTIVE THERAPEUTICS, INC.

Attorney

Carrie Webb Olson

Filing Date

Jan 19, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PHARMACEUTICALLY ELEGANT Trademark

Serial Number: 97227033

PHARMACEUTICALLY ELEGANT is a trademark filed by AQUESTIVE THERAPEUTICS, INC. on January 19, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

AQUESTIVE THERAPEUTICS, INC. (82 trademarks)

30 Technology Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

January 19, 2022

Registration Date

Not Registered

Published for Opposition

May 10, 2022

Goods & Services

Drug delivery agents in the form of oral soluble film, sublingual film, and transmucosal film that facilitate the delivery of prescription pharmaceutical drug preparations; films dissolvable in the mouth for the oral delivery of prescription pharmaceutical drug preparations; pharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, inflammatory, pain, respiratory, hormonal, central nervous system, and psychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy, seizure disorders, and psychiatric disorders; pharmaceutical preparations for the prevention and treatment of sexual dysfunction; pharmaceutical preparations, namely, anticonvulsants, antiseizure medications, psychotropics, benzodiazepines, and mood stabilizing medications; pharmaceutical preparations for the treatment or prevention of allergic reaction, anaphylaxis, and asthma; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, hypertension, and pulmonary arterial hypertension; pharmaceutical preparations for the treatment of benign prostatic hyperplasia; pharmaceutical preparations for the treatment of migraine, tension, and cluster headaches

Research and development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Medical and scientific research in the fields of pharmaceuticals, medicine, and therapeutics; Consulting services in the fields of pharmaceutical research and development

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 11, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 11, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 28, 2025 EXRA
SOU EXTENSION 5 GRANTED
Mar 27, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 25, 2025 AITU
SOU EXTENSION 5 FILED
Nov 26, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 26, 2024 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 26, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 26, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 26, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 26, 2024 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2024 EXRA
SOU EXTENSION 4 GRANTED
May 14, 2024 EX4G
SOU EXTENSION 4 FILED
May 14, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
May 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 15, 2023 EXRA
SOU EXTENSION 3 GRANTED
Nov 13, 2023 EX3G
SOU EXTENSION 3 FILED
Nov 13, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 13, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 1, 2023 EXRA
SOU EXTENSION 2 GRANTED
May 30, 2023 EX2G
SOU EXTENSION 2 FILED
May 30, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
May 30, 2023 EEXT
ASSIGNED TO EXAMINER
Feb 13, 2023 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 16, 2022 EXRA
SOU EXTENSION 1 GRANTED
Dec 14, 2022 EX1G
SOU EXTENSION 1 FILED
Dec 14, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 14, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 25, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 25, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 25, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 25, 2022 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 5, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 10, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 10, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 20, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 28, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 28, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 28, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 28, 2022 CNEA
ASSIGNED TO EXAMINER
Mar 16, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 25, 2022 NWOS
NEW APPLICATION ENTERED
Jan 22, 2022 NWAP